1 row is stored for this page
| Field | Field type | Value |
|---|
| generic | String | Venlafaxine |
| brand | String | Effexor XR, Effexor IR (discontinued in US, generic widely available) |
| structure | File | |
| classes | List of String, delimiter: , | [[:Category:SNRIs|Serotonin-norepinephrine reuptake inhibitor (SNRI)]] • [[:Category:Antidepressants|Antidepressant]] • [[:Category:Anxiolytics|Anxiolytic]] |
| mechanism | String | |
| uses | String | '"`UNIQ--vote-0000001F-QINU`"', '"`UNIQ--vote-00000020-QINU`"', '"`UNIQ--vote-00000021-QINU`"', '"`UNIQ--vote-00000022-QINU`"', '"`UNIQ--vote-00000023-QINU`"', '"`UNIQ--vote-00000024-QINU`"', '"`UNIQ--vote-00000025-QINU`"' |
| starting_dose | String | XR 37.5 mg PO once daily for 4-7 days, then 75 mg/day; titrate by 75 mg every ≥4 days to clinical effect. IR 25-37.5 mg BID-TID |
| preparations | String | IR tablets 25, 37.5, 50, 75, 100 mg; XR capsules 37.5, 75, 150, 225 mg |
| fda_max | String | 225 mg/day outpatient (XR); 375 mg/day inpatient (IR divided TID); 75 mg/day in moderate hepatic impairment |
| pill_id | Text | |
| routes | List of String, delimiter: , | Oral |
| onset | String | Antidepressant effect over 1-2 weeks; anxiolytic effect over 4-6 weeks |
| duration | String | 24 hours (XR); 12 hours (IR) |
| halflife | String | Venlafaxine 5 hours; desvenlafaxine active metabolite 11 hours'"`UNIQ--ref-00000026-QINU`"' |
| bioavailability | String | ~45%'"`UNIQ--ref-00000027-QINU`"' |
| pregnancy | String | Observational signal for neonatal adaptation syndrome with late-pregnancy exposure; weigh against the risks of untreated maternal depression.<sup class="pcp-cn" title="This claim needs a citation.">[[[Pharmacopedia:Citation needed|citation needed]]]</sup> |
| legal | String | [[USLegal:Prescription only|Rx-only]] in US. Carries the antidepressant '''Boxed Warning''' for suicidality in children, adolescents, and young adults'"`UNIQ--ref-00000028-QINU`"' |
